Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study.
Al Sulaiman K, Aljuhani O, Korayem GB, Hafiz A, Alalawi M, Badreldin HA, Altebainawi AF, Vishwakarma R, Alissa A, Alghamdi A, Alenazi AA, Al Enazi H, Alanazi S, Alhammad A, Alghamdi J, AlFaifi M, Al Sehli FA, Aldossari MA, Alhubaishi AA, Al-Ali AY, Al-Dorzi HM. Al Sulaiman K, et al. Among authors: alhammad a. Thromb J. 2022 Dec 8;20(1):74. doi: 10.1186/s12959-022-00432-9. Thromb J. 2022. PMID: 36482388 Free PMC article.
Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study.
Al Sulaiman K, Aljuhani O, Saleh KB, Badreldin HA, Al Harthi A, Alenazi M, Alharbi A, Algarni R, Al Harbi S, Alhammad AM, Vishwakarma R, Aldekhyl S. Al Sulaiman K, et al. Among authors: alhammad am. Sci Rep. 2021 Sep 24;11(1):19433. doi: 10.1038/s41598-021-99146-7. Sci Rep. 2021. PMID: 34561522 Free PMC article. No abstract available.
Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study.
Aljuhani O, Al Sulaiman K, Alshabasy A, Eljaaly K, Al Shaya AI, Noureldeen H, Aboudeif M, Al Dosari B, Alkhalaf A, Korayem GB, Aleissa MM, Badreldin HA, Al Harbi S, Alhammad A, Vishwakarma R. Aljuhani O, et al. Among authors: alhammad a. BMC Infect Dis. 2021 Nov 1;21(1):1127. doi: 10.1186/s12879-021-06813-1. BMC Infect Dis. 2021. PMID: 34724920 Free PMC article.
The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study.
Al Sulaiman K, Aljuhani O, Alhammad AM, Al Aamer K, Alshehri S, Alhuwahmel A, Kharbosh A, Alshehri A, Alshareef H, Al Sulaihim I, Alghamdi A, Al Harbi S, Vishwakarma R, Alabdan N, Alrajhi Y, Al Katheri A, Alenazi AA, Alalawi M, Al Ghamdi G. Al Sulaiman K, et al. Among authors: alhammad am. Saudi Pharm J. 2022 Dec;30(12):1748-1754. doi: 10.1016/j.jsps.2022.10.003. Epub 2022 Oct 8. Saudi Pharm J. 2022. PMID: 36601502 Free PMC article.
Clinical pharmacy services in acute care setting during mass gatherings (Hajj): Insights from a task force.
Aljuhani O, Al Sulaiman K, Bekairy AMA, Almajed K, Harbi MA, Thabit AK, Alharthi AF, Aldardeer N, Badreldin HA, Alhammad AM, Alenazi AO, Alghamdi B, Alsohimi S, Alshennawi M, Alshaya AI, Alrashed M, Al Shaya OA, Al-Jedai A. Aljuhani O, et al. Among authors: alhammad am. J Infect Public Health. 2024 Apr;17 Suppl 1:68-75. doi: 10.1016/j.jiph.2023.05.023. Epub 2023 May 20. J Infect Public Health. 2024. PMID: 37271687 Free article.
Characteristics of Critical Care Pharmacy Services in Saudi Arabia.
Ismail NH, Alhammad AM, Alshaya AI, Alkhani N, Alenazi AO, Aljuhani O. Ismail NH, et al. Among authors: alhammad am. J Multidiscip Healthc. 2023 Nov 1;16:3227-3234. doi: 10.2147/JMDH.S434116. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 37933261 Free PMC article.
Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study.
Aldardeer NF, Alshreef MM, Alharbi EA, Aljabri AK, Aljawadi MH, Almangour TA, Alobaili S, Alarifi MI, Alomari A, Alhammad AM. Aldardeer NF, et al. Among authors: alhammad am. Open Forum Infect Dis. 2024 Feb 1;11(3):ofae059. doi: 10.1093/ofid/ofae059. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38434610 Free PMC article. Clinical Trial.
Multidrug-Resistant and Extensively Drug-Resistant Enterobacteriaceae: Prevalence, Treatments, and Outcomes - A Retrospective Cohort Study.
Alkofide H, Alhammad AM, Alruwaili A, Aldemerdash A, Almangour TA, Alsuwayegh A, Almoqbel D, Albati A, Alsaud A, Enani M. Alkofide H, et al. Among authors: alhammad am. Infect Drug Resist. 2020 Dec 24;13:4653-4662. doi: 10.2147/IDR.S283488. eCollection 2020. Infect Drug Resist. 2020. PMID: 33380815 Free PMC article.
70 results